A study indicated that high PFKP expression induced intracellular citrate accumulation in breast cancer, leading to significantly enhanced cell migration and invasion through the AKT/ERK/MMP2/MMP9 signaling axis 36. The gene discussed is PFKP; the disease is breast cancer.